Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024 as against Rs 42.31 crore during the previous quarter ended September 2023. Sales rose 2.74% to Rs 217.68 crore in the quarter ended September 2024 as against Rs 211.88 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 217.68 | 211.88 | 3 |
| OPM % | 19.05 | 25.66 | - |
| PBDT | 42.69 | 65.52 | -35 |
| PBT | 35.71 | 59.13 | -40 |
| NP | 24.26 | 42.31 | -43 |